{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T04:30:55Z","timestamp":1748579455616,"version":"3.30.2"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-024-01657-y","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T10:22:15Z","timestamp":1734517335000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["HSP and CD279 gene expression as candidate biomarkers in symptomatic LGLL patients"],"prefix":"10.1007","volume":"15","author":[{"given":"Giovanna","family":"Talarico","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Franceschini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Raveane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Falvo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saveria","family":"Mazzara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Melle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"Motta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Orecchioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annamaria","family":"Tenore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuliana","family":"Gregato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Poletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Chiarle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Pileri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia","family":"Mancuso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Bertolini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,18]]},"reference":[{"issue":"7","key":"1657_CR1","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","volume":"36","author":"R Alaggio","year":"2022","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, et al. The 5th edition of the world health organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia. 2022;36(7):1720\u201348. https:\/\/doi.org\/10.1038\/s41375-022-01620-2.","journal-title":"Leukemia."},{"issue":"4","key":"1657_CR2","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1182\/blood.2022019016","volume":"141","author":"E Campo","year":"2023","unstructured":"Campo E, Jaffe ES, Cook JR, et al. the international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee. Blood. 2023;141(4):437. https:\/\/doi.org\/10.1182\/blood.2022019016.","journal-title":"Blood."},{"issue":"21","key":"1657_CR3","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1182\/blood.2022015854","volume":"140","author":"L de Leval","year":"2022","unstructured":"de Leval L, Alizadeh AA, Bergsagel PL, et al. Genomic profiling for clinical decision making in lymphoid neoplasms. Blood. 2022;140(21):2193\u2013227. https:\/\/doi.org\/10.1182\/blood.2022015854.","journal-title":"Blood"},{"issue":"5","key":"1657_CR4","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1182\/blood.V80.5.1116.1116","volume":"80","author":"TPJ Loughran","year":"1992","unstructured":"Loughran TPJ, Coyle T, Sherman MP, et al. Detection of human T-cell leukemia\/lymphoma virus, type II, in a patient with large granular lymphocyte leukemia. Blood. 1992;80(5):1116\u20139.","journal-title":"Blood"},{"issue":"5","key":"1657_CR5","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1182\/blood.V90.5.1977","volume":"90","author":"TPJ Loughran","year":"1997","unstructured":"Loughran TPJ, Hadlock KG, Yang Q, et al. Seroreactivity to an envelope protein of human T-cell leukemia\/lymphoma virus in patients with CD3- (natural killer) lymphoproliferative disease of granular lymphocytes. Blood. 1997;90(5):1977\u201381.","journal-title":"Blood"},{"issue":"4","key":"1657_CR6","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.leukres.2004.08.010","volume":"29","author":"L Sokol","year":"2005","unstructured":"Sokol L, Agrawal D, Loughran TPJ. Characterization of HTLV envelope seroreactivity in large granular lymphocyte leukemia. Leuk Res. 2005;29(4):381\u20137. https:\/\/doi.org\/10.1016\/j.leukres.2004.08.010.","journal-title":"Leuk Res"},{"issue":"1","key":"1657_CR7","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1182\/blood-2011-04-346759","volume":"119","author":"J Chen","year":"2012","unstructured":"Chen J, Petrus M, Bamford R, et al. Increased serum soluble IL-15Ralpha levels in T-cell large granular lymphocyte leukemia. Blood. 2012;119(1):137\u201343. https:\/\/doi.org\/10.1182\/blood-2011-04-346759.","journal-title":"Blood"},{"issue":"12","key":"1657_CR8","doi-asserted-by":"publisher","first-page":"4771","DOI":"10.1182\/blood.V92.12.4771","volume":"92","author":"T Lamy","year":"1998","unstructured":"Lamy T, Liu JH, Landowski TH, Dalton WS, Loughran TPJ. Dysregulation of CD95\/CD95 ligand-apoptotic pathway in CD3(+) large granular lymphocyte leukemia. Blood. 1998;92(12):4771\u20137.","journal-title":"Blood"},{"issue":"4","key":"1657_CR9","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1182\/blood.V100.4.1449.h81602001449_1449_1453","volume":"100","author":"JH Liu","year":"2002","unstructured":"Liu JH, Wei S, Lamy T, et al. Blockade of fas-dependent apoptosis by soluble FAS in LGL leukemia. Blood. 2002;100(4):1449\u201353.","journal-title":"Blood"},{"issue":"19","key":"1657_CR10","doi-asserted-by":"publisher","first-page":"3843","DOI":"10.1182\/blood-2012-07-441378","volume":"121","author":"A Teramo","year":"2013","unstructured":"Teramo A, Gattazzo C, Passeri F, et al. Intrinsic and extrinsic mechanisms contribute to maintain the JAK\/STAT pathway aberrantly activated in T-type large granular lymphocyte leukemia. Blood. 2013;121(19):3843\u201354, S1. https:\/\/doi.org\/10.1182\/blood-2012-07-441378.","journal-title":"Blood."},{"issue":"3","key":"1657_CR11","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1182\/blood-2007-06-093823","volume":"111","author":"J Yang","year":"2008","unstructured":"Yang J, Epling-Burnette PK, Painter JS, et al. Antigen activation and impaired fas-induced death-inducing signaling complex formation in T-large-granular lymphocyte leukemia. Blood. 2008;111(3):1610\u20136. https:\/\/doi.org\/10.1182\/blood-2007-06-093823.","journal-title":"Blood"},{"issue":"42","key":"1657_CR12","doi-asserted-by":"publisher","first-page":"16308","DOI":"10.1073\/pnas.0806447105","volume":"105","author":"R Zhang","year":"2008","unstructured":"Zhang R, Shah MV, Yang J, et al. Network model of survival signaling in large granular lymphocyte leukemia. Proc Natl Acad Sci USA. 2008;105(42):16308\u201313. https:\/\/doi.org\/10.1073\/pnas.0806447105.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"1657_CR13","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/ng0501-29","volume":"28","author":"H Yoshikawa","year":"2001","unstructured":"Yoshikawa H, Matsubara K, Qian GS, et al. SOCS-1, a negative regulator of the JAK\/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity. Nat Genet. 2001;28(1):29\u201335. https:\/\/doi.org\/10.1038\/ng0501-29.","journal-title":"Nat Genet"},{"issue":"20","key":"1657_CR14","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1056\/NEJMoa1114885","volume":"366","author":"HLM Koskela","year":"2012","unstructured":"Koskela HLM, Eldfors S, Ellonen P, et al. Somatic STAT3 mutations in large granular lymphocytic leukemia. N Engl J Med. 2012;366(20):1905\u201313. https:\/\/doi.org\/10.1056\/NEJMoa1114885.","journal-title":"N Engl J Med"},{"issue":"15","key":"1657_CR15","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1182\/blood-2012-06-435297","volume":"120","author":"A Jerez","year":"2012","unstructured":"Jerez A, Clemente MJ, Makishima H, et al. STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia. Blood. 2012;120(15):3048\u201357. https:\/\/doi.org\/10.1182\/blood-2012-06-435297.","journal-title":"Blood"},{"issue":"7","key":"1657_CR16","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1038\/leu.2012.350","volume":"27","author":"A Fasan","year":"2013","unstructured":"Fasan A, Kern W, Grossmann V, Haferlach C, Haferlach T, Schnittger S. STAT3 mutations are highly specific for large granular lymphocytic leukemia. Leukemia. 2013;27(7):1598\u2013600. https:\/\/doi.org\/10.1038\/leu.2012.350.","journal-title":"Leukemia"},{"issue":"10","key":"1657_CR17","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.3390\/cells10102800","volume":"10","author":"G Calabretto","year":"2021","unstructured":"Calabretto G, Teramo A, Barila G, et al. Neutropenia and large granular lymphocyte leukemia: from pathogenesis to therapeutic options. Cells. 2021;10(10):2800. https:\/\/doi.org\/10.3390\/cells10102800.","journal-title":"Cells"},{"issue":"1","key":"1657_CR18","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.1038\/s41467-022-31015-x","volume":"13","author":"A Teramo","year":"2022","unstructured":"Teramo A, Binatti A, Ciabatti E, et al. Defining TCRgammadelta lymphoproliferative disorders by combined immunophenotypic and molecular evaluation. Nat Commun. 2022;13(1):3298\u2013x. https:\/\/doi.org\/10.1038\/s41467-022-31015-x.","journal-title":"Nat Commun"},{"issue":"4","key":"1657_CR19","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1038\/s41375-019-0644-0","volume":"34","author":"G Barila","year":"2020","unstructured":"Barila G, Teramo A, Calabretto G, et al. Stat3 mutations impact on overall survival in large granular lymphocyte leukemia: a single-center experience of 205 patients. Leukemia. 2020;34(4):1116\u201324. https:\/\/doi.org\/10.1038\/s41375-019-0644-0.","journal-title":"Leukemia"},{"issue":"12","key":"1657_CR20","doi-asserted-by":"publisher","first-page":"3508","DOI":"10.3390\/cancers12123508","volume":"12","author":"N Munoz-Garcia","year":"2020","unstructured":"Munoz-Garcia N, Jara-Acevedo M, Caldas C, et al. STAT3 and STAT5B mutations in T\/NK-cell chronic lymphoproliferative disorders of large granular lymphocytes (LGL): association with disease features. Cancers (Basel). 2020;12(12):3508. https:\/\/doi.org\/10.3390\/cancers12123508.","journal-title":"Cancers (Basel)"},{"issue":"2","key":"1657_CR21","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41408-022-00630-8","volume":"12","author":"D Bhattacharya","year":"2022","unstructured":"Bhattacharya D, Teramo A, Gasparini VR, et al. Identification of novel STAT5B mutations and characterization of TCRbeta signatures in CD4+ T-cell large granular lymphocyte leukemia. Blood Cancer J. 2022;12(2):31\u20138. https:\/\/doi.org\/10.1038\/s41408-022-00630-8.","journal-title":"Blood Cancer J"},{"issue":"25","key":"1657_CR22","doi-asserted-by":"publisher","first-page":"4077","DOI":"10.1182\/blood-2013-05-506386","volume":"122","author":"MJ Clemente","year":"2013","unstructured":"Clemente MJ, Przychodzen B, Jerez A, et al. Deep sequencing of the T-cell receptor repertoire in CD8+ T-large granular lymphocyte leukemia identifies signature landscapes. Blood. 2013;122(25):4077\u201385. https:\/\/doi.org\/10.1182\/blood-2013-05-506386.","journal-title":"Blood"},{"issue":"11","key":"1657_CR23","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.3390\/cancers13112611","volume":"13","author":"K Klein","year":"2021","unstructured":"Klein K, Stoiber D, Sexl V, Witalisz-Siepracka A. Untwining anti-tumor and immunosuppressive effects of JAK inhibitors\u2014a strategy for hematological malignancies? Cancers (Basel). 2021;13(11):2611. https:\/\/doi.org\/10.3390\/cancers13112611.","journal-title":"Cancers (Basel)"},{"issue":"20","key":"1657_CR24","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1182\/blood-2016-06-724856","volume":"128","author":"EI Andersson","year":"2016","unstructured":"Andersson EI, Tashi T, Sekiguchi N, et al. High incidence of activating STAT5B mutations in CD4-positive T-cell large granular lymphocyte leukemia. Blood. 2016;128(20):2465\u20138. https:\/\/doi.org\/10.1182\/blood-2016-06-724856.","journal-title":"Blood"},{"issue":"22","key":"1657_CR25","doi-asserted-by":"publisher","first-page":"4541","DOI":"10.1182\/blood-2012-12-474577","volume":"121","author":"HLM Rajala","year":"2013","unstructured":"Rajala HLM, Eldfors S, Kuusanmaki H, et al. Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia. Blood. 2013;121(22):4541\u201350. https:\/\/doi.org\/10.1182\/blood-2012-12-474577.","journal-title":"Blood"},{"issue":"9","key":"1657_CR26","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1182\/blood.2021013489","volume":"141","author":"G Barila","year":"2023","unstructured":"Barila G, Grassi A, Cheon H, et al. Tgammadelta LGLL identifies a subset with more symptomatic disease: analysis of an international cohort of 137 patients. Blood. 2023;141(9):1036\u201346. https:\/\/doi.org\/10.1182\/blood.2021013489.","journal-title":"Blood"},{"issue":"2","key":"1657_CR27","doi-asserted-by":"publisher","first-page":"324","DOI":"10.3109\/10428194.2014.921297","volume":"56","author":"Z Qiu","year":"2015","unstructured":"Qiu Z, Shen W, Fan L, et al. Assessment of clonality in T-cell large granular lymphocytic leukemia: flow cytometric T cell receptor vbeta repertoire and T cell receptor gene rearrangement. Leuk Lymphoma. 2015;56(2):324\u201331. https:\/\/doi.org\/10.3109\/10428194.2014.921297.","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"1657_CR28","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1016\/s0002-9440(10)63032-5","volume":"159","author":"M Lima","year":"2001","unstructured":"Lima M, Almeida J, Santos AH, et al. Immunophenotypic analysis of the TCR-vbeta repertoire in 98 persistent expansions of CD3(+)\/TCR-alphabeta(+) large granular lymphocytes: utility in assessing clonality and insights into the pathogenesis of the disease. Am J Pathol. 2001;159(5):1861\u20138. https:\/\/doi.org\/10.1016\/s0002-9440(10)63032-5.","journal-title":"Am J Pathol"},{"issue":"1","key":"1657_CR29","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1182\/blood.v98.1.165","volume":"98","author":"AW Langerak","year":"2001","unstructured":"Langerak AW, van Den Beemd R, Wolvers-Tettero IL, et al. Molecular and flow cytometric analysis of the vbeta repertoire for clonality assessment in mature TCRalphabeta T-cell proliferations. Blood. 2001;98(1):165\u201373. https:\/\/doi.org\/10.1182\/blood.v98.1.165.","journal-title":"Blood"},{"issue":"10","key":"1657_CR30","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1182\/blood-2010-07-296962","volume":"117","author":"T Lamy","year":"2011","unstructured":"Lamy T, Loughran TPJ. How I treat LGL leukemia. Blood. 2011;117(10):2764\u201374. https:\/\/doi.org\/10.1182\/blood-2010-07-296962.","journal-title":"Blood"},{"key":"1657_CR31","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.3389\/fimmu.2019.02035","volume":"10","author":"TS Kapellos","year":"2019","unstructured":"Kapellos TS, Bonaguro L, Gemund I, et al. Human monocyte subsets and phenotypes in major chronic inflammatory diseases. Front Immunol. 2019;10:2035. https:\/\/doi.org\/10.3389\/fimmu.2019.02035.","journal-title":"Front Immunol"},{"issue":"56","key":"1657_CR32","doi-asserted-by":"publisher","first-page":"9041","DOI":"10.1038\/sj.onc.1207114","volume":"22","author":"S Takayama","year":"2003","unstructured":"Takayama S, Reed JC, Homma S. Heat-shock proteins as regulators of apoptosis. Oncogene. 2003;22(56):9041\u20137. https:\/\/doi.org\/10.1038\/sj.onc.1207114.","journal-title":"Oncogene"},{"issue":"3","key":"1657_CR33","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1159\/000296508","volume":"2","author":"A Joly","year":"2010","unstructured":"Joly A, Wettstein G, Mignot G, Ghiringhelli F, Garrido C. Dual role of heat shock proteins as regulators of apoptosis and innate immunity. J Innate Immun. 2010;2(3):238\u201347. https:\/\/doi.org\/10.1159\/000296508.","journal-title":"J Innate Immun"},{"issue":"3","key":"1657_CR34","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/s41388-019-1016-y","volume":"39","author":"L Dubrez","year":"2020","unstructured":"Dubrez L, Causse S, Borges Bonan N, Dumetier B, Garrido C. Heat-shock proteins: chaperoning DNA repair. Oncogene. 2020;39(3):516\u201329. https:\/\/doi.org\/10.1038\/s41388-019-1016-y.","journal-title":"Oncogene"},{"issue":"1","key":"1657_CR35","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s13277-010-0088-7","volume":"32","author":"L Sedlackova","year":"2011","unstructured":"Sedlackova L, Spacek M, Holler E, Imryskova Z, Hromadnikova I. Heat-shock protein expression in leukemia. Tumour Biol. 2011;32(1):33\u201344. https:\/\/doi.org\/10.1007\/s13277-010-0088-7.","journal-title":"Tumour Biol"},{"key":"1657_CR36","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3389\/fmolb.2019.00148","volume":"6","author":"VK Pidugu","year":"2019","unstructured":"Pidugu VK, Pidugu HB, Wu M, Liu C, Lee T. Emerging functions of human IFIT proteins in cancer. Front Mol Biosci. 2019;6:148. https:\/\/doi.org\/10.3389\/fmolb.2019.00148.","journal-title":"Front Mol Biosci"},{"issue":"3","key":"1657_CR37","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/tbj.12097","volume":"19","author":"HH Danish","year":"2013","unstructured":"Danish HH, Goyal S, Taunk NK, Wu H, Moran MS, Haffty BG. Interferon-induced protein with tetratricopeptide repeats 1 (IFIT1) as a prognostic marker for local control in T1\u20132 N0 breast cancer treated with breast-conserving surgery and radiation therapy (BCS + RT). Breast J. 2013;19(3):231\u20139. https:\/\/doi.org\/10.1111\/tbj.12097.","journal-title":"Breast J"},{"key":"1657_CR38","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.humpath.2016.01.013","volume":"52","author":"J Zhang","year":"2016","unstructured":"Zhang J, Chen Y, Lin G, et al. High IFIT1 expression predicts improved clinical outcome, and IFIT1 along with MGMT more accurately predicts prognosis in newly diagnosed glioblastoma. Hum Pathol. 2016;52:136\u201344. https:\/\/doi.org\/10.1016\/j.humpath.2016.01.013.","journal-title":"Hum Pathol"},{"issue":"1","key":"1657_CR39","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/hep.29156","volume":"66","author":"Y Yang","year":"2017","unstructured":"Yang Y, Zhou Y, Hou J, et al. Hepatic IFIT3 predicts interferon-alpha therapeutic response in patients of hepatocellular carcinoma. Hepatology. 2017;66(1):152\u201366. https:\/\/doi.org\/10.1002\/hep.29156.","journal-title":"Hepatology"},{"issue":"6","key":"1657_CR40","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1007\/s00432-017-2351-4","volume":"143","author":"Y Zhao","year":"2017","unstructured":"Zhao Y, Altendorf-Hofmann A, Pozios I, et al. Elevated interferon-induced protein with tetratricopeptide repeats 3 (IFIT3) is a poor prognostic marker in pancreatic ductal adenocarcinoma. J Cancer Res Clin Oncol. 2017;143(6):1061\u20138. https:\/\/doi.org\/10.1007\/s00432-017-2351-4.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"4","key":"1657_CR41","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.3892\/ijmm.2020.4500","volume":"45","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Li N, Liu S, et al. Overexpression of IFIT2 inhibits the proliferation of chronic myeloid leukemia cells by regulating the BCR-ABL\/AKT\/mTOR pathway. Int J Mol Med. 2020;45(4):1187\u201394. https:\/\/doi.org\/10.3892\/ijmm.2020.4500.","journal-title":"Int J Mol Med"},{"issue":"3","key":"1657_CR42","doi-asserted-by":"publisher","first-page":"383","DOI":"10.7150\/ijbs.17236","volume":"13","author":"L Chen","year":"2017","unstructured":"Chen L, Liu S, Xu F, et al. Inhibition of proteasome activity induces aggregation of IFIT2 in the centrosome and enhances IFIT2-induced cell apoptosis. Int J Biol Sci. 2017;13(3):383\u201390. https:\/\/doi.org\/10.7150\/ijbs.17236.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"1657_CR43","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/cyto.a.22351","volume":"85","author":"A Larbi","year":"2014","unstructured":"Larbi A, Fulop T. From, \u201ctruly na\u00efve\u201d to \u201cexhausted senescent\u201d T cells: when markers predict functionality. Cytometry A. 2014;85(1):25\u201335. https:\/\/doi.org\/10.1002\/cyto.a.22351.","journal-title":"Cytometry A"},{"key":"1657_CR44","doi-asserted-by":"publisher","first-page":"630","DOI":"10.3389\/fimmu.2014.00630","volume":"5","author":"J Geginat","year":"2014","unstructured":"Geginat J, Paroni M, Maglie S, et al. Plasticity of human CD4 T cell subsets. Front Immunol. 2014;5:630. https:\/\/doi.org\/10.3389\/fimmu.2014.00630.","journal-title":"Front Immunol"},{"issue":"9","key":"1657_CR45","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1093\/intimm\/dxn075","volume":"20","author":"R Okada","year":"2008","unstructured":"Okada R, Kondo T, Matsuki F, Takata H, Takiguchi M. Phenotypic classification of human CD4+ T cell subsets and their differentiation. Int Immunol. 2008;20(9):1189\u201399. https:\/\/doi.org\/10.1093\/intimm\/dxn075.","journal-title":"Int Immunol"},{"issue":"10","key":"1657_CR46","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/s41590-020-0758-6","volume":"21","author":"SS Ng","year":"2020","unstructured":"Ng SS, De Labastida RF, Yan J, et al. The NK cell granule protein NKG7 regulates cytotoxic granule exocytosis and inflammation. Nat Immunol. 2020;21(10):1205\u201318. https:\/\/doi.org\/10.1038\/s41590-020-0758-6.","journal-title":"Nat Immunol"},{"issue":"5","key":"1657_CR47","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.it.2019.03.001","volume":"40","author":"CL Scott","year":"2019","unstructured":"Scott CL, Omilusik KD. ZEBs: Novel players in immune cell development and function. Trends Immunol. 2019;40(5):431\u201346. https:\/\/doi.org\/10.1016\/j.it.2019.03.001.","journal-title":"Trends Immunol"},{"key":"1657_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.967737","volume":"13","author":"A Rigamonti","year":"2022","unstructured":"Rigamonti A, Castagna A, Viatore M, et al. Distinct responses of newly identified monocyte subsets to advanced gastrointestinal cancer and COVID-19. Front Immunol. 2022;13: 967737. https:\/\/doi.org\/10.3389\/fimmu.2022.967737.","journal-title":"Front Immunol"},{"issue":"8","key":"1657_CR49","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1016\/j.immuni.2021.07.007","volume":"54","author":"K Mulder","year":"2021","unstructured":"Mulder K, Patel AA, Kong WT, et al. Cross-tissue single-cell landscape of human monocytes and macrophages in health and disease. Immunity. 2021;54(8):1883-1900.e5. https:\/\/doi.org\/10.1016\/j.immuni.2021.07.007.","journal-title":"Immunity"},{"issue":"4","key":"1657_CR50","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/0092-8674(88)90076-1","volume":"54","author":"R Chiu","year":"1988","unstructured":"Chiu R, Boyle WJ, Meek J, Smeal T, Hunter T, Karin M. The c-fos protein interacts with c-jun\/AP-1 to stimulate transcription of AP-1 responsive genes. Cell. 1988;54(4):541\u201352. https:\/\/doi.org\/10.1016\/0092-8674(88)90076-1.","journal-title":"Cell"},{"issue":"2","key":"1657_CR51","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.ajhg.2020.01.002","volume":"106","author":"M Wagner","year":"2020","unstructured":"Wagner M, Skorobogatko Y, Pode-Shakked B, et al. Bi-allelic variants in RALGAPA1 cause profound neurodevelopmental disability, muscular hypotonia, infantile spasms, and feeding abnormalities. Am J Hum Genet. 2020;106(2):246\u201355. https:\/\/doi.org\/10.1016\/j.ajhg.2020.01.002.","journal-title":"Am J Hum Genet"},{"key":"1657_CR52","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.3389\/fimmu.2018.01298","volume":"9","author":"S Wang","year":"2018","unstructured":"Wang S, Song R, Wang Z, Jing Z, Wang S, Ma J. S100A8\/A9 in inflammation. Front Immunol. 2018;9:1298. https:\/\/doi.org\/10.3389\/fimmu.2018.01298.","journal-title":"Front Immunol"},{"issue":"1","key":"1657_CR53","doi-asserted-by":"publisher","first-page":"4360","DOI":"10.1038\/s41467-021-24537-3","volume":"12","author":"S Prekovic","year":"2021","unstructured":"Prekovic S, Schuurman K, Mayayo-Peralta I, et al. Glucocorticoid receptor triggers a reversible drug-tolerant dormancy state with acquired therapeutic vulnerabilities in lung cancer. Nat Commun. 2021;12(1):4360\u20133. https:\/\/doi.org\/10.1038\/s41467-021-24537-3.","journal-title":"Nat Commun"},{"issue":"4","key":"1657_CR54","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1002\/JLB.2A0421-200R","volume":"111","author":"R Silva-Gomes","year":"2022","unstructured":"Silva-Gomes R, Mapelli SN, Boutet M, et al. Differential expression and regulation of MS4A family members in myeloid cells in physiological and pathological conditions. J Leukoc Biol. 2022;111(4):817\u201336. https:\/\/doi.org\/10.1002\/JLB.2A0421-200R.","journal-title":"J Leukoc Biol"},{"key":"1657_CR55","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.3389\/fonc.2020.01512","volume":"10","author":"J Luo","year":"2020","unstructured":"Luo J, Wang J, Zheng H, Wang L. Rho GDP-dissociation inhibitor 2 inhibits C\u2013X\u2013C chemokine receptor type 4-mediated acute lymphoblastic leukemia cell migration. Front Oncol. 2020;10:1512. https:\/\/doi.org\/10.3389\/fonc.2020.01512.","journal-title":"Front Oncol"},{"issue":"1","key":"1657_CR56","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3349\/ymj.2007.48.1.11","volume":"48","author":"SY Choo","year":"2007","unstructured":"Choo SY. The HLA system: Genetics, immunology, clinical testing, and clinical implications. Yonsei Med J. 2007;48(1):11\u201323. https:\/\/doi.org\/10.3349\/ymj.2007.48.1.11.","journal-title":"Yonsei Med J"},{"key":"1657_CR57","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.isci.2018.12.015","volume":"11","author":"MV Baranov","year":"2019","unstructured":"Baranov MV, Bianchi F, Schirmacher A, et al. The phosphoinositide kinase PIKfyve promotes cathepsin-S-mediated major histocompatibility complex class II antigen presentation. iScience. 2019;11:160\u201377. https:\/\/doi.org\/10.1016\/j.isci.2018.12.015.","journal-title":"iScience."},{"issue":"1","key":"1657_CR58","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.coi.2011.11.004","volume":"24","author":"MED Schulze","year":"2012","unstructured":"Schulze MED, Wucherpfennig KW. The mechanism of HLA-DM induced peptide exchange in the MHC class II antigen presentation pathway. Curr Opin Immunol. 2012;24(1):105\u201311. https:\/\/doi.org\/10.1016\/j.coi.2011.11.004.","journal-title":"Curr Opin Immunol"},{"issue":"13","key":"1657_CR59","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1161\/hc3801.095588","volume":"104","author":"AD Michelson","year":"2001","unstructured":"Michelson AD, Barnard MR, Krueger LA, Valeri CR, Furman MI. Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: studies in baboons, human coronary intervention, and human acute myocardial infarction. Circulation. 2001;104(13):1533\u20137. https:\/\/doi.org\/10.1161\/hc3801.095588.","journal-title":"Circulation"},{"issue":"41","key":"1657_CR60","doi-asserted-by":"publisher","first-page":"25712","DOI":"10.1073\/pnas.2002476117","volume":"117","author":"Y Hu","year":"2020","unstructured":"Hu Y, Hu Y, Xiao Y, et al. Genetic landscape and autoimmunity of monocytes in developing Vogt-Koyanagi-Harada disease. Proc Natl Acad Sci USA. 2020;117(41):25712\u201321. https:\/\/doi.org\/10.1073\/pnas.2002476117.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1657_CR61","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","volume":"26","author":"ME Keir","year":"2008","unstructured":"Keir ME, Butte MJ, Freeman GJ, Sharpe AH. PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol. 2008;26:677\u2013704. https:\/\/doi.org\/10.1146\/annurev.immunol.26.021607.090331.","journal-title":"Annu Rev Immunol"},{"issue":"6","key":"1657_CR62","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/ni.2035","volume":"12","author":"EJ Wherry","year":"2011","unstructured":"Wherry EJ. T cell exhaustion. Nat Immunol. 2011;12(6):492\u20139. https:\/\/doi.org\/10.1038\/ni.2035.","journal-title":"Nat Immunol"},{"issue":"20","key":"1657_CR63","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1182\/blood.2021013164","volume":"139","author":"H Cheon","year":"2022","unstructured":"Cheon H, Xing JC, Moosic KB, et al. Genomic landscape of TCRalphabeta and TCRgammadelta T-large granular lymphocyte leukemia. Blood. 2022;139(20):3058\u201372. https:\/\/doi.org\/10.1182\/blood.2021013164.","journal-title":"Blood"},{"issue":"9","key":"1657_CR64","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1182\/blood-2016-08-692590","volume":"129","author":"T Lamy","year":"2017","unstructured":"Lamy T, Moignet A, Loughran TPJ. LGL leukemia: from pathogenesis to treatment. Blood. 2017;129(9):1082\u201394. https:\/\/doi.org\/10.1182\/blood-2016-08-692590.","journal-title":"Blood"},{"issue":"11","key":"1657_CR65","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1038\/s41375-022-01695-x","volume":"36","author":"G Semenzato","year":"2022","unstructured":"Semenzato G, Teramo A, Calabretto G, Gasparini VR, Zambello R. All that glitters is not LGL leukemia. Leukemia. 2022;36(11):2551\u20137. https:\/\/doi.org\/10.1038\/s41375-022-01695-x.","journal-title":"Leukemia"},{"key":"1657_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115505","volume":"211","author":"Z Alimardan","year":"2023","unstructured":"Alimardan Z, Abbasi M, Hasanzadeh F, Aghaei M, Khodarahmi G, Kashfi K. Heat shock proteins and cancer: the FoxM1 connection. Biochem Pharmacol. 2023;211: 115505. https:\/\/doi.org\/10.1016\/j.bcp.2023.115505.","journal-title":"Biochem Pharmacol"},{"issue":"12","key":"1657_CR67","doi-asserted-by":"publisher","first-page":"3502","DOI":"10.1172\/JCI40599","volume":"119","author":"A Stutz","year":"2009","unstructured":"Stutz A, Golenbock DT, Latz E. Inflammasomes: too big to miss. J Clin Invest. 2009;119(12):3502\u201311. https:\/\/doi.org\/10.1172\/JCI40599.","journal-title":"J Clin Invest"},{"issue":"4","key":"1657_CR68","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.immuni.2016.01.012","volume":"44","author":"MM Gaidt","year":"2016","unstructured":"Gaidt MM, Ebert TS, Chauhan D, et al. Human monocytes engage an alternative inflammasome pathway. Immunity. 2016;44(4):833\u201346. https:\/\/doi.org\/10.1016\/j.immuni.2016.01.012.","journal-title":"Immunity"},{"issue":"5379","key":"1657_CR69","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1126\/science.281.5379.998","volume":"281","author":"MX Wu","year":"1998","unstructured":"Wu MX, Ao Z, Prasad KV, Wu R, Schlossman SF. IEX-1L, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival. Science. 1998;281(5379):998\u20131001. https:\/\/doi.org\/10.1126\/science.281.5379.998.","journal-title":"Science"},{"issue":"2","key":"1657_CR70","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/s41375-018-0267-x","volume":"33","author":"Z Ping","year":"2019","unstructured":"Ping Z, Chen S, Hermans SJF, et al. Activation of NF-kappaB driven inflammatory programs in mesenchymal elements attenuates hematopoiesis in low-risk myelodysplastic syndromes. Leukemia. 2019;33(2):536\u201341. https:\/\/doi.org\/10.1038\/s41375-018-0267-x.","journal-title":"Leukemia"},{"issue":"9","key":"1657_CR71","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/ncb0901-839","volume":"3","author":"L Ravagnan","year":"2001","unstructured":"Ravagnan L, Gurbuxani S, Susin SA, et al. Heat-shock protein 70 antagonizes apoptosis-inducing factor. Nat Cell Biol. 2001;3(9):839\u201343. https:\/\/doi.org\/10.1038\/ncb0901-839.","journal-title":"Nat Cell Biol"},{"issue":"3","key":"1657_CR72","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.4049\/jimmunol.160.3.1449","volume":"160","author":"CM McManus","year":"1998","unstructured":"McManus CM, Brosnan CF, Berman JW. Cytokine induction of MIP-1 alpha and MIP-1 beta in human fetal microglia. J Immunol. 1998;160(3):1449\u201355.","journal-title":"J Immunol"},{"issue":"3","key":"1657_CR73","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1002\/art.37819","volume":"65","author":"J Wang","year":"2013","unstructured":"Wang J, Tian Y, Phillips KLE, et al. Tumor necrosis factor alpha- and interleukin-1beta-dependent induction of CCL3 expression by nucleus pulposus cells promotes macrophage migration through CCR1. Arthritis Rheum. 2013;65(3):832\u201342. https:\/\/doi.org\/10.1002\/art.37819.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"1657_CR74","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1093\/jnen\/59.5.339","volume":"59","author":"JA Shukaliak","year":"2000","unstructured":"Shukaliak JA, Dorovini-Zis K. Expression of the beta-chemokines RANTES and MIP-1 beta by human brain microvessel endothelial cells in primary culture. J Neuropathol Exp Neurol. 2000;59(5):339\u201352. https:\/\/doi.org\/10.1093\/jnen\/59.5.339.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"18","key":"1657_CR75","doi-asserted-by":"publisher","first-page":"4658","DOI":"10.3390\/ijms20184658","volume":"20","author":"S Sindhu","year":"2019","unstructured":"Sindhu S, Kochumon S, Shenouda S, Wilson A, Al-Mulla F, Ahmad R. The cooperative induction of CCL4 in human monocytic cells by TNF-alpha and palmitate requires MyD88 and involves MAPK\/NF-kappaB signaling pathways. Int J Mol Sci. 2019;20(18):4658. https:\/\/doi.org\/10.3390\/ijms20184658.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1657_CR76","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3324\/haematol.2022.282306","volume":"109","author":"C Vicenzetto","year":"2024","unstructured":"Vicenzetto C, Gasparini VR, Barila G, et al. Pro-inflammatory cells sustain leukemic clonal expansion in T-cell large granular lymphocyte leukemia. Haematologica. 2024;109(1):163\u201374. https:\/\/doi.org\/10.3324\/haematol.2022.282306.","journal-title":"Haematologica"},{"issue":"4","key":"1657_CR77","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","volume":"15","author":"DE Johnson","year":"2018","unstructured":"Johnson DE, O\u2019Keefe RA, Grandis JR. Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer. Nat Rev Clin Oncol. 2018;15(4):234\u201348. https:\/\/doi.org\/10.1038\/nrclinonc.2018.8.","journal-title":"Nat Rev Clin Oncol"},{"issue":"12","key":"1657_CR78","doi-asserted-by":"publisher","first-page":"3430","DOI":"10.1038\/s41375-021-01296-0","volume":"35","author":"D Kim","year":"2021","unstructured":"Kim D, Park G, Huuhtanen J, et al. STAT3 activation in large granular lymphocyte leukemia is associated with cytokine signaling and DNA hypermethylation. Leukemia. 2021;35(12):3430\u201343. https:\/\/doi.org\/10.1038\/s41375-021-01296-0.","journal-title":"Leukemia"},{"issue":"5","key":"1657_CR79","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1136\/jclinpath-2016-204023","volume":"70","author":"FB da Silva","year":"2017","unstructured":"da Silva FB, Machado-Neto JA, Bertini VH, Lipoli L, et al. Single-nucleotide polymorphism array (SNP-A) improves the identification of chromosomal abnormalities by metaphase cytogenetics in myelodysplastic syndrome. J Clin Pathol. 2017;70(5):435\u201342. https:\/\/doi.org\/10.1136\/jclinpath-2016-204023.","journal-title":"J Clin Pathol."},{"issue":"10","key":"1657_CR80","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1038\/leu.2012.246","volume":"26","author":"AW Langerak","year":"2012","unstructured":"Langerak AW, Groenen PJTA, Bruggemann M, et al. EuroClonality\/BIOMED-2 guidelines for interpretation and reporting of ig\/TCR clonality testing in suspected lymphoproliferations. Leukemia. 2012;26(10):2159\u201371. https:\/\/doi.org\/10.1038\/leu.2012.246.","journal-title":"Leukemia"},{"issue":"1","key":"1657_CR81","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/s41420-022-00893-x","volume":"8","author":"L Carpen","year":"2022","unstructured":"Carpen L, Falvo P, Orecchioni S, et al. A single-cell transcriptomic landscape of innate and adaptive intratumoral immunity in triple negative breast cancer during chemo- and immunotherapies. Cell Death Discov. 2022;8(1):106\u2013x. https:\/\/doi.org\/10.1038\/s41420-022-00893-x.","journal-title":"Cell Death Discov"},{"issue":"3","key":"1657_CR82","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1158\/0008-5472.CAN-20-1818","volume":"81","author":"P Falvo","year":"2021","unstructured":"Falvo P, Orecchioni S, Hillje R, et al. Cyclophosphamide and vinorelbine activate stem-like CD8(+) T cells and improve anti-PD-1 efficacy in triple-negative breast cancer. Cancer Res. 2021;81(3):685\u201397.","journal-title":"Cancer Res"},{"key":"1657_CR83","doi-asserted-by":"publisher","first-page":"979","DOI":"10.12688\/f1000research.73600.2","volume":"10","author":"P Germain","year":"2021","unstructured":"Germain P, Lun A, Garcia Meixide C, Macnair W, Robinson MD. Doublet identification in single-cell sequencing data using scDblFinder. F1000Res. 2021;10:979. https:\/\/doi.org\/10.12688\/f1000research.73600.2.","journal-title":"F1000Res."},{"issue":"17","key":"1657_CR84","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1093\/bioinformatics\/btz031","volume":"35","author":"J Rainer","year":"2019","unstructured":"Rainer J, Gatto L, Weichenberger CX. Ensembldb: an R package to create and use ensembl-based annotation resources. Bioinformatics. 2019;35(17):3151\u20133. https:\/\/doi.org\/10.1093\/bioinformatics\/btz031.","journal-title":"Bioinformatics"},{"issue":"1","key":"1657_CR85","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/s13059-019-1874-1","volume":"20","author":"C Hafemeister","year":"2019","unstructured":"Hafemeister C, Satija R. Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression. Genome Biol. 2019;20(1):296\u20131. https:\/\/doi.org\/10.1186\/s13059-019-1874-1.","journal-title":"Genome Biol"},{"issue":"2","key":"1657_CR86","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","volume":"20","author":"D Aran","year":"2019","unstructured":"Aran D, Looney AP, Liu L, et al. Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat Immunol. 2019;20(2):163\u201372. https:\/\/doi.org\/10.1038\/s41590-018-0276-y.","journal-title":"Nat Immunol"},{"key":"1657_CR87","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1186\/1471-2164-14-632","volume":"14","author":"NA Mabbott","year":"2013","unstructured":"Mabbott NA, Baillie JK, Brown H, Freeman TC, Hume DA. An expression atlas of human primary cells: inference of gene function from coexpression networks. BMC Genomics. 2013;14:632\u2013632. https:\/\/doi.org\/10.1186\/1471-2164-14-632.","journal-title":"BMC Genomics"},{"issue":"10","key":"1657_CR88","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.3324\/haematol.2013.094243","volume":"98","author":"JHA Martens","year":"2013","unstructured":"Martens JHA, Stunnenberg HG. BLUEPRINT: mapping human blood cell epigenomes. Haematologica. 2013;98(10):1487\u20139. https:\/\/doi.org\/10.3324\/haematol.2013.094243.","journal-title":"Haematologica"},{"issue":"2","key":"1657_CR89","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.cell.2011.01.004","volume":"144","author":"N Novershtern","year":"2011","unstructured":"Novershtern N, Subramanian A, Lawton LN, et al. Densely interconnected transcriptional circuits control cell states in human hematopoiesis. Cell. 2011;144(2):296\u2013309. https:\/\/doi.org\/10.1016\/j.cell.2011.01.004.","journal-title":"Cell"},{"issue":"6","key":"1657_CR90","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/j.celrep.2019.01.041","volume":"26","author":"G Monaco","year":"2019","unstructured":"Monaco G, Lee B, Xu W, et al. RNA-seq signatures normalized by mRNA abundance allow absolute deconvolution of human immune cell types. Cell Rep. 2019;26(6):1627-1640.e7. https:\/\/doi.org\/10.1016\/j.celrep.2019.01.041.","journal-title":"Cell Rep"},{"key":"1657_CR91","doi-asserted-by":"publisher","DOI":"10.1093\/database\/baz046","author":"O Franzen","year":"2019","unstructured":"Franzen O, Gan L, Bjorkegren JLM. PanglaoDB: a web server for exploration of mouse and human single-cell RNA sequencing data. Database (Oxford). 2019. https:\/\/doi.org\/10.1093\/database\/baz046.","journal-title":"Database (Oxford)."},{"issue":"18","key":"1657_CR92","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","volume":"32","author":"Z Gu","year":"2016","unstructured":"Gu Z, Eils R, Schlesner M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics. 2016;32(18):2847\u20139. https:\/\/doi.org\/10.1093\/bioinformatics\/btw313.","journal-title":"Bioinformatics"},{"issue":"1","key":"1657_CR93","doi-asserted-by":"publisher","first-page":"vbac070","DOI":"10.1093\/bioadv\/vbac070","volume":"2","author":"M Del Corvo","year":"2022","unstructured":"Del Corvo M, Mazzara S, Pileri SA. TOSCA: an automated tumor only somatic CAlling workflow for somatic mutation detection without matched normal samples. Bioinform Adv. 2022;2(1):vbac070. https:\/\/doi.org\/10.1093\/bioadv\/vbac070.","journal-title":"Bioinform Adv."}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-024-01657-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-024-01657-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-024-01657-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T11:24:41Z","timestamp":1734521081000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-024-01657-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,18]]},"references-count":93,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1657"],"URL":"https:\/\/doi.org\/10.1007\/s12672-024-01657-y","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,18]]},"assertion":[{"value":"9 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research was approved by ethics committee of the European Institute of Oncology. Patients signed an appropriate informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"764"}}